Zobrazeno 1 - 10
of 76
pro vyhledávání: '"BEAT MEYER"'
Publikováno v:
Studies in health technology and informatics. 293
The European health care industry faces massive changes which impose new challenges on its stakeholders.In this paper, we present the results of a market-based analysis for upcoming changes in the European health care industry and what this specifica
Background: The European health care industry faces massive changes which impose new challenges on its stakeholders. Objective: In this paper, we present the results of a market-based analysis for upcoming changes in the European health care industry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf8811f1112d2231af25e9f02bca6f72
https://doi.org/10.3233/shti220355
https://doi.org/10.3233/shti220355
Publikováno v:
Surgery for Obesity and Related Diseases. 9:e38-e40
Autor:
Beat Meyer
Sulfur, Energy, and Environment is a guide to the properties of sulfur; its three important compounds; and a review of the production, use, and recovery of sulfur in relation to energy production and environmental protection. After a brief introducti
Autor:
H S Merki, Jürgen Drewe, Christoph Beglinger, Frank Serge Lehmann, Beat Meyer-Wyss, Charles Ruchti, Luca Mazzucchelli, Clive H. Wilder-Smith, Eberhard L. Renner
Publikováno v:
Digestion. 62:82-86
Background/Aims: Helicobacter pylori is considered to be the primary cause of most forms of gastritis, but its role as a causative agent in gastric erosions is unclear. The aim of this study was to estimate the prevalence of gastric erosions and H. p
Publikováno v:
World Journal of Surgery. 18:406-409
The short- and long-term bleeding recurrence and mortality of 157 consecutive patients admitted emergently over a period of 2 years with an actively bleeding peptic ulcer were analyzed. They were treated uniformly according to a defined approach wher
Publikováno v:
Gut. 34:752-756
The relation between Helicobacter pylori (H pylori) infection and fasting gastrin and pepsinogen-I and -II concentrations was evaluated in 278 volunteers without symptoms and the results were compared with the values obtained in 35 patients with duod
Publikováno v:
Hepatology. 13:475-481
Hepatic drug metabolism is decreased in patients with severe liver disease, but it is unclear to what extent this is due to altered hepatic blood flow or reduced intrinsic metabolic capacity. In this study we quantitated in needle-biopsy specimens th
Autor:
Martin Wilhelmi, Beat Meyer-Wyss, Alicia Esteban, Jean-Jacques Gonvers, Ivan Stamenic, Marina Knöpfli, Sabine Dinges, Eberhard L. Renner, Jan Borovicka, Andreas Cerny, Beat Helbling, Wolfram Jochum, Beat Müllhaupt
Publikováno v:
Journal of viral hepatitis. 13(11)
In patients with hepatitis C virus (HCV)-related advanced fibrosis/cirrhosis, 30% of sustained HCV clearance has been reported with pegylated interferon alpha-2a (PEG-IFN) alone, but the efficacy and tolerability of the PEG-IFN/ribavirin (RBV) combin
Autor:
Eberhard L. Renner, D. Criblez, Beat Meyer-Wyss, Hp Egger, Jean-Jacques Gonvers, L. Rossi, M. Arn, Christa Meyenberger, Beat Müllhaupt, P. Rich, C. Rammert, Beat Helbling, Carl Oneta, Jan Borovicka
Publikováno v:
Journal of viral hepatitis. 13(7)
Health regulatory approval of the 1.5 microg/kg body weight dose of pegylated interferon (PEG-I) alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C was based on a study using PEG-I alpha-2b at doses of only 0.5 and 1.5 mi